Unitree Technology Floats 10% Stake in Shanghai with Massive Retail Demand Expected
China’s leading AI-driven humanoid robotics firm Unitree Technology launched its initial public offering on the Shanghai STAR Market today, becoming the first company with humanoid robots as its core business to list on the A-share board. The offering price was set at 150.8 yuan per share, implying a post-issue market capitalisation of approximately 60.99 billion yuan (US$8.4 billion). Retail and institutional investors flocked to the highly anticipated float, with market estimates suggesting the online lottery win rate will plunge to just 0.02–0.03% — one of the tightest in recent STAR board history.
Given a board lot size of 500 shares, an investor who secures an allocation must commit 75,400 yuan. If the stock merely matches the average 276% first-day pop of other A-share IPOs this year, a single board lot would generate an unrealised profit of around 208,000 yuan. The company plans to issue 40.45 million new shares, raising gross proceeds of 60.99 billion yuan, well above its earlier 42.02 billion yuan target. Funds are earmarked for developing humanoid and quadrupedal robots, upgrading core hardware and software, launching new products, and building production bases to scale capacity.
Unitree’s financials have improved dramatically: revenue jumped from 159 million yuan in 2023 to 1.7 billion yuan in 2025, a compound annual growth rate of 227%, while net profit swung from a loss to 591 million yuan. Gross margins hit 60.1%, with humanoid-robot-related margins reaching 63.2%. Founder Wang Xingxing directly and indirectly controls 33.36% of the economic interest and, through a dual-class share structure, commands 68.78% of voting rights, ensuring continued control post-IPO. Early backers including Tencent and DeepSeek stand to book significant notional gains.
Why the IPO’s Rich Valuation Hinges on Flawless Execution
Pioneer Premium vs. Execution Reality
Unitree’s first-mover advantage in humanoid robots is undeniable, but the offering documents highlight a major risk: the business is moving from a period of explosive, early-stage growth into a phase where industrial-scale production, cost management, and product iteration will determine long-term viability. While revenue surged 332.6% in 2025, first-quarter 2026 growth decelerated to 68.5% year-on-year, and core net profit fell 52.6%. Founder Wang acknowledged that a higher base, a cooling of speculative hype, and intensifying competition all contributed to the slowdown. The question for public investors is whether Unitree can sustain margins and win large-volume orders from logistics, manufacturing and service sectors, where competition is already heating up.
Valuation Overlap: 219 Times Earnings as a Double-Edged Sword
The 219.23x price-to-earnings multiple dwarfs the sector average of 38.56x. Management argues that comparable robot firms are mostly loss-making, whereas Unitree has demonstrated strong profitability. Yet the market is effectively pricing in several years of uninterrupted hyper-growth. If humanoid-robot adoption takes longer than expected, or if larger rivals drive down pricing, the stock could face a sharp re-rating. Even the company’s own risk disclosure flags potential fluctuations in operating performance. Retail punters who dive in purely for a first-day flip will be betting that broader market sentiment and the ‘humanoid robot first stock’ scarcity premium hold until they can exit.
Founder’s Grip and Early Investors’ Cashing-In
Wang Xingxing’s dual-class voting structure leaves him firmly in charge, which can be an advantage for a technology-intensive company that needs long-term vision, but also raises governance concerns for minority shareholders. At the listing price, Wang’s direct and indirect stake is worth approximately 20.3 billion yuan. Meanwhile, strategic investors such as Tencent and DeepSeek, while subject to lock-ups, could use the listing as a liquidity event. A large overhang of unlocked shares will eventually hit the market, adding to valuation pressure once the lock-up periods expire.
What Investors Should Watch as Unitree Shares Start Trading
- If you are participating in the retail offering, be aware that the 0.02–0.03% lottery rate means a board-lot application has a near-zero probability of success; temper expectations and consider this a low-probability punt rather than a core allocation.
- Do not extrapolate the illustrative 276% first-day gain to every lottery winner. The average is skewed by a handful of spectacular debuts, and Unitree’s 219x P/E already bakes in enormous optimism — any hint of disappointment on the first trading day could erase those paper profits quickly.
- Track the company’s second-quarter 2026 delivery figures and any volume order announcements from logistics, manufacturing or service-industry customers. These will be the first real test of whether the humanoid robot pipeline is commercialising at scale.
- Mark the six-month and twelve-month lock-up expiry dates for early investors and the founder. When these sell-down windows open, large block trades could put downward pressure on the stock, especially if early backers are sitting on several times their cost basis.
- For institutional and professional investors, compare Unitree with global humanoid-robot developers such as Boston Dynamics (Hyundai-owned), Tesla’s Optimus, and Xiaomi’s CyberOne. Monitor whether competitor manufacturing roadmaps or pricing cuts could erode Unitree’s premium before it achieves mass adoption.
Risk & Opportunity Assessment
| Commercial Risk | High | Revenue growth decelerated from 332% in FY2025 to 68% in Q1 2026 and net profit fell 52%, suggesting that the early hyper-growth phase has peaked and the company’s ability to sustain margins and scale orders remains unproven. |
| Competitive Risk | High | Humanoid robotics is attracting deep-pocketed players globally, including Tesla, Xiaomi, and state-backed Chinese initiatives. Price competition and ability to land large commercial contracts ahead of rivals are critical unknowns for Unitree. |
| Regulatory Risk | Medium | STAR board listing rules and China’s evolving oversight of tech IPOs could tighten, affecting secondary trading or future fundraising. However, no immediate regulatory action is flagged in the prospectus. |
| Reputation Risk | Medium | As the first pure-play humanoid robot listing, Unitree becomes a bellwether for the sector. A high-profile post-IPO disappointment—such as missed delivery targets or product safety issues—could damage not only its brand but also investor appetite for the broader robotics theme. |
| Technology Disruption | High | Advances in embodied AI, sensors, and battery technology could quickly shift the competitive landscape. Unitree’s current lead in quadrupedal and humanoid platforms is not a patent-protected moat, and faster-moving rivals could leapfrog its product iterations. |
| Commercial Opportunity | High | The global humanoid robot market is still nascent, and Unitree’s early commercialisation, combined with the fresh capital from the IPO, positions it to capture a sizeable share of demand in logistics, inspection, and service roles if execution stays on track. |
Comments 0